Evidence map›Paper›PMID 41835036›Full record

ArticleCureus2026

Regenerative Synergy in Facial Rejuvenation: A Pilot Clinical Study of Polydioxanone Microspheres (Ultra V® UltraCol 200), Organic Silicon, and Adipostructuring.

Marta Amin, Victor Mercado, Gladys Velazco, Valentina Corvalan, Han Jin Kwon

Abstract read
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Marta AminDentistry, Instituto Chileno de Rejuvenecimiento y Optimización en Medicina Estética, Viña del Mar, CHL.
Victor MercadoOtolaryngology, Instituto de Neurorrehabilitación y Equilibrio, Viña del Mar, CHL.
Gladys VelazcoRegenerative and Aesthetic Medicine, Centro Latinoamericano de Entrenamiento Médico e Investigación, Bogotá, COL.
Valentina CorvalanAesthetic Medicine, Clínica Roma, Santiago, CHL.
Han Jin KwonDermatology, UltraV Co. Ltd. Research and Development Center and Dermaster Clinic Network, Seoul, KOR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Dermal fillers used with minimally invasive techniques have currently achieved an important role in regenerative medicine and in alleviating skin damage over the years. Objectives To evaluate clinical results after the use of the Polydioxanone Collagen Biostimulator Ultra V® UltraCol 200 (Ultracol), commonly referred to as PDO microspheres, with the addition of organic silicon to enhance Ultracol biostimulation, using the adipostructuring technique in a group of older patients who consulted to improve the quality of their skin. Materials and methods The study included 20 patients (3 men and 17 women), aged 40 to 80 years. We used Ultracol plus organic silicon. Injections were performed using the facial adipostructuring technique, with a 22-gauge, 50-mm cannula, injecting 2.5 mL per hemiface in a single session. We evaluated results at 10 days and 2 months after the procedure using photography and parameters selected by a blinded evaluator, along with a satisfaction survey. Results Clinical evaluation demonstrated noticeable improvement in facial tridimensionality, with enhanced volumetric projection and contour definition. A reduction in nasolabial fold depth was observed, along with improved vertical positioning of the malar region. Additionally, better definition of the infraorbital area was noted, accompanied by a subtle increase in supraperiosteal volume. Overall, these changes were considered favorable outcomes in this treated older patient group. Conclusion Ultracol plus organic silicon, using the facial adipostructuring technique in a group of older patients, can be considered a suitable and safe therapeutic alternative.

Indexed as

adipostructuringliquid polydioxanoneneocollagenesisorganic siliconsynergyultracol 200 ultrav

Identifiers

PMID41835036
PMCPMC12980266

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.